SDT 2005_09 New Zealand Federation of Body Builders vs Steven Ward

The New Zealand Sports Drug Agency (NZSD) and the New Zealand Federation of Bodybuilders (NZFBB) have reported an anti-doping rule violation against the Respondent after his sample tested positive for the substances Stanozolol, Nandrolone and Furosemide.

The Respondent accepted that he committed an anti-doping violation. He admitted to the Tribunal that he had made a conscious decision to take the drugs and that the decision had now backfired on him. He had been advised that the drugs would assist his performance and he took them knowing of the consequences if he got caught.
The World Anti-Doping Code (WADA Code) provides for a mandatory two year suspension for a first violation involving these substances unless the athlete can show “no fault or negligence” or “no significant fault or negligence”. The Respondent accepted that these exceptions did not apply to him.

The Sports Disputes Tribunal of New Zealand decides to impose a 2 year period of ineligibility on the Respondent starting on the date of this decision.
The Respondent is ineligible to participate in any capacity in a competition or activity (other than authorised anti-doping education rehabilitation programmes), authorised or organised by NZFBB or any other signatory to the WADA Code.

Original document

Parameters

Legal Source
National Decisions
Date
7 October 2005
Arbitrator
Palmer, Farah
Paterson, Barry
Toogood, Kit
Original Source
Sports Disputes Tribunal of New Zealand
Country
New Zealand
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Drug Free Sport New Zealand (DFSNZ)
New Zealand Federation of Bodybuilders (NZFBB)
New Zealand Sports Drug Agency (NZSDA)
Laboratories
Sydney, Australia: Australian Sports Drug Testing Laboratory (ASDTL) - Sydney (AUS)
Doping classes
S1. Anabolic Agents
S5. Diuretics and Other Masking Agents
Substances
Furosemide
Nandrolone (19-nortestosterone)
Stanozolol
Document type
Pdf file
Date generated
24 October 2013
Date of last modification
12 September 2016
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin